Features A - Z
View Features alphabetically
- A Brave New Electronic World
- A Healthy Approach to Climate Change
- A more permeable pathway – next generation transdermal drug delivery
- A New Era for Drug Delivery
- A new era of drug safety: European pharmacovigilance
- A New Pharmaceutical World Order
- A vital new path for schizophrenia treatment
- A World of Trials
- Accelerating the search for new TB drugs - he who shares wins
- All Natural: The Rise of Cannabinoid Medicine
- An Historic Day for HIV?
- Anthrax outbreak – are current drug options enough?
- Antibodies: An Industry Almost Ready to Attack
- API compliance – safeguarding the supply chain
- Around the World in 80 Days
- At War With Antimicrobial Resistance
- Avastin vs. Lucentis: trialling a blindness prevention drug
- Challenging Times for Gene Sequencing Patents
- Changing Pharma IT with Biobank
- Clinical trial delays: America’s patient recruitment dilemma
- Combating the Counterfeit Culture
- Contract Chemistry: The Custom Synthesis Market
- Controlling Clinical Contracting
- Counterfeit Drugs: What the Doctor Didn't Order
- Countering Bioterrorism
- Countering the Contagious: Countermeasures Under US Review
- The Paediatric Medication Controversy
- Paediatric Trials and Tribulations
- Partnerships and Pandemics: Preparing for 2010
- The patent cliff: rise of the generics
- Pfizer and the Business of Being Good
- Pharma Regulation: Quality by Design?
- Pharma Technology Focus - Issue 10
- Pharma Technology Focus - Issue 11
- Pharma Technology Focus - Issue 12
- Pharma Technology Focus - Issue 13
- Pharma Technology Focus - Issue 5
- Pharma Technology Focus - Issue 6
- Pharma Technology Focus - Issue 8
- Pharma Technology Focus - Issue 9
- Pharma Technology Focus – Issue 1 Out Now
- Pharma Technology Focus – Issue 2 Out Now
- Pharma Technology Focus – Issue 3 Out Now
- Pharma Technology Focus – Issue 4 Out Now
- Pharma Technology Focus – Issue 7
- Pharma's CEO Hotlist for 2010
- Pharmaceutical Packaging and Labelling for Safety
- Pinpoint accuracy: programmable nanoparticles and future cancer treatments
- Preparing for a Pandemic
- Preventing the Fallout: Anti-Radiation Drugs
- Scandinavia Shows off E-Prescription Success
- Security in Serialisation: Tracking Packaging Technology
- Simulating the Supply Chain
- Small players, big drugs – pharmaceutical SMEs take the innovative edge
- Smarter, faster, cheaper: three ways for API manufacturers to stay ahead of the game
- Snapshot H1N1 (swine influenza) – the post-pandemic pipeline
- Snapshot: Coronary Artery Disease Global Clinical Trials 2011
- Snapshot: Pulmonary Hypertension Global Clinical Trials
- Snapshot: Respiration Disorders Global Clinical Trials
- Snapshot: The market for neuropathic pain therapeutics
- Standardised Pricing Strategies in Clinical Trials
- Stem Cells: Going Behind the Trials
- Straight to the source – targeted pain relief
- Supply Chain Management in Healthcare
- Swine Flu – Know the Facts
- Swine Flu – The Race for Jab to Remove the Sting
- Take a load off: the age of cloud computing
- Take the Competitive Edge in Pharmaceuticals
- Taking aim with nanotechnology
- That's teamwork: Pharma puts its faith in partnerships
- The Advantage of Adaptation
- The cholesterol polypill – a global cure-all?
- The Elusive Alzheimer's Cure
- The Fight Against Drug Resistance
- The Problems and Promises of Stem Cell Research
- The Race for a Malaria Vaccine
- The fake drug war: spotlight on Europe and the US
- The Write Stuff
- Top 5 expired blockbuster drugs
- Tracing Supply Chain Standards
- Transforming Tomorrow's Clinical Trials
- Trial and Error: Finding Focus with Clinical IT
- Trials and Tribulations of the Growing Biosimilars Market
- Truvada – finally a pharmaceutical answer to HIV prevention?
- Tumour-targeting ADCs: delivering the anti-cancer warhead
Twitter
Facebook